197 related articles for article (PubMed ID: 20074001)
21. [In silico, in vitro, in omic experimental models and drug safety evaluation].
Claude N; Goldfain-Blanc F; Guillouzo A
Med Sci (Paris); 2009 Jan; 25(1):105-10. PubMed ID: 19154704
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a robust QSAR model for prediction of carcinogenicity of drugs.
Kar S; Roy K
Indian J Biochem Biophys; 2011 Apr; 48(2):111-22. PubMed ID: 21682143
[TBL] [Abstract][Full Text] [Related]
23. Clustering and its application in multi-target prediction.
Liu W; Johnson DE
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):98-107. PubMed ID: 19152218
[TBL] [Abstract][Full Text] [Related]
24. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
25. Integrated decision support for assessing chemical liabilities.
Spjuth O; Eklund M; Ahlberg Helgee E; Boyer S; Carlsson L
J Chem Inf Model; 2011 Aug; 51(8):1840-7. PubMed ID: 21774475
[TBL] [Abstract][Full Text] [Related]
26. The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries.
Modi S; Hughes M; Garrow A; White A
Drug Discov Today; 2012 Feb; 17(3-4):135-42. PubMed ID: 22063083
[TBL] [Abstract][Full Text] [Related]
27. Mitigating permeability-mediated risks in drug discovery.
Wang J; Skolnik S
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):171-87. PubMed ID: 20064074
[TBL] [Abstract][Full Text] [Related]
28. Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models.
Contrera JF; Kruhlak NL; Matthews EJ; Benz RD
Regul Toxicol Pharmacol; 2007 Dec; 49(3):172-82. PubMed ID: 17703860
[TBL] [Abstract][Full Text] [Related]
29. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
30. In silico predictive metabolism: a structural/electronic filter method.
Harris DL
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):43-8. PubMed ID: 14982147
[TBL] [Abstract][Full Text] [Related]
31. A conceptual framework for predicting the toxicity of reactive chemicals: modeling soft electrophilicity.
Schultz TW; Carlson RE; Cronin MT; Hermens JL; Johnson R; O'Brien PJ; Roberts DW; Siraki A; Wallace KB; Veith GD
SAR QSAR Environ Res; 2006 Aug; 17(4):413-28. PubMed ID: 16920662
[TBL] [Abstract][Full Text] [Related]
32. Quantitative structure-toxicity relationships by accelerated cytotoxicity mechanism screening.
Siraki AG; Chevaldina T; Moridani MY; O'Brien PJ
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):118-25. PubMed ID: 14982155
[TBL] [Abstract][Full Text] [Related]
33. A combined approach to drug metabolism and toxicity assessment.
Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Sorokina S; Bugrim A; Nikolskaya T
Drug Metab Dispos; 2006 Mar; 34(3):495-503. PubMed ID: 16381662
[TBL] [Abstract][Full Text] [Related]
34. In silico prediction of harmful effects triggered by drugs and chemicals.
Vedani A; Dobler M; Lill MA
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):398-407. PubMed ID: 16045954
[TBL] [Abstract][Full Text] [Related]
35. Regulatory use of computational toxicology tools and databases at the United States Food and Drug Administration's Office of Food Additive Safety.
Arvidson KB; Chanderbhan R; Muldoon-Jacobs K; Mayer J; Ogungbesan A
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):793-6. PubMed ID: 20491519
[TBL] [Abstract][Full Text] [Related]
36. Substance-tailored testing strategies in toxicology: an in silico methodology based on QSAR modeling of toxicological thresholds and Monte Carlo simulations of toxicological testing.
Péry AR; Desmots S; Mombelli E
Regul Toxicol Pharmacol; 2010 Feb; 56(1):82-92. PubMed ID: 19766156
[TBL] [Abstract][Full Text] [Related]
37. Chemoinformatics and chemical genomics: potential utility of in silico methods.
Valerio LG; Choudhuri S
J Appl Toxicol; 2012 Nov; 32(11):880-9. PubMed ID: 22886396
[TBL] [Abstract][Full Text] [Related]
38. Local and global quantitative structure-activity relationship modeling and prediction for the baseline toxicity.
Yuan H; Wang Y; Cheng Y
J Chem Inf Model; 2007; 47(1):159-69. PubMed ID: 17238261
[TBL] [Abstract][Full Text] [Related]
39. In silico fragment-based drug design.
Konteatis ZD
Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
[TBL] [Abstract][Full Text] [Related]
40. Computational methods to predict drug safety liabilities.
Durham SK; Pearl GM
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):110-5. PubMed ID: 11727316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
